Innovating Works

JANSSEN DI

A stranger
ND4ID: New Diagnostics for Infectious Diseases ND4ID Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid poin...
2015-07-31 - 2020-02-29 | financed
CHAARM: Combined Highly Active Anti retroviral Microbicides JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7 This proposal is for a large scale collaborative project in which we propose both to develop novel microbicides directed against new intrace...
financed
THINC: TARGETING HIV INTEGRATION CO FACTORS TARGETING CELLULAR PROTEINS DURING NUCLEAR IMPORT OR INTEGRATI... JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7 Standard therapy of infection with the human immunodeficiency virus type 1 (HIV-1) is based on potent cocktails of drugs targeting viral pro...
financed
EUVIRNA: European Training Network on RNA Virus Replication and Antiviral Drug Development JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7 Virus infections remain a major cause of disease, with dramatic costs in mortality, morbidity, and economic loss worldwide. There is an unme...
financed
CHAIN: Collaborative HIV and Anti HIV Drug Resistance Network JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7 CHAIN is a large scale integrating project aimed to effectively and durably combat new and existing anti-HIV drug resistance in clinical set...
financed
PREPARE: Platform foR European Preparedness Against Re emerging Epidemics JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7 Far from receding, the threats posed by infections with epidemic potential grow ever greater. Although Europe has amongst the best healthcar...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.